The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma
Metrics: PDF 1366 views | HTML 1958 views | ?
Magdalena Kijewska1, Marta Kocyk1, Michal Kloss1, Karolina Stepniak1, Zbigniew Korwek2, Renata Polakowska3, Michal Dabrowski1, Anna Gieryng1, Bartosz Wojtas1, Iwona A. Ciechomska1, Bozena Kaminska1
1Laboratory Molecular Neurobiology, The Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland
2Laboratory Molecular Bases of Aging, The Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland
3Jean-Pierre Aubert Research Center, INSERM U837, Lille, France
Bozena Kaminska, email: firstname.lastname@example.org
Keywords: osteopontin, glioma initiating cells, transcription factors, stemness factors, self-renewal
Received: February 19, 2016 Accepted: December 16, 2016 Published: December 22, 2016
Osteopontin (SPP1, a secreted phosphoprotein 1) is primarily involved in immune responses, tissue remodelling and biomineralization. However, it is also overexpressed in many cancers and regulates tumour progression by increasing migration, invasion and cancer stem cell self-renewal. Mechanisms of SPP1 overexpression in gliomas are poorly understood. We demonstrate overexpression of two out of five SPP1 isoforms in glioblastoma (GBM) and differential isoform expression in glioma cell lines. Up-regulated SPP1 expression is associated with binding of the GLI1 transcription factor to the promoter and OCT4 (octamer-binding transcription factor 4) to the first SPP1 intron of the SPP1 gene in human glioma cells but not in non-transformed astrocytes. GLI1 knockdown reduced SPP1 mRNA and protein levels in glioma cells. GLI1 and OCT4 are known regulators of stem cell pluripotency. GBMs contain rare cells that express stem cell markers and display ability to self-renew. We reveal that SPP1 is overexpressed in glioma initiating cells defined by high rhodamine 123 efflux, sphere forming capacity and stemness marker expression. Forced differentiation of human glioma spheres reduced SPP1 expression. Knockdown of SPP1, GLI1 or CD44 with siRNAs diminished sphere formation. C6 glioma cells stably depleted of Spp1 displayed reduced sphere forming capacity and downregulated stemness marker expression. Overexpression of the wild type Spp1, but not Spp1 lacking a Cd44 binding domain, rescued cell ability to form spheres. Our findings show re-activation of the embryonic-type transcriptional regulation of SPP1 in malignant gliomas and point to the importance of SPP1-CD44 interactions in self-renewal and pluripotency glioma initiating cells.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.